Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1184130

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1184130

Global Human Combination Vaccines Market 2023-2027

PUBLISHED:
PAGES: 168 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Technavio has been monitoring the human combination vaccines market and is forecast to grow by $6046.98 mn during 2022-2027, accelerating at a CAGR of 8.13% during the forecast period. Our report on the human combination vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing antiviral drug resistance, increase in pediatric population, and rise in cases of infectious diseases.

Technavio's human combination vaccines market is segmented as below:

By Type

  • Inactivated vaccine
  • Live attenuated vaccine

By Channel

  • Hospitals
  • Retailers
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the threat from bioterrorism as one of the prime reasons driving the human combination vaccines market growth during the next few years. Also, growing interest in research and development of new vaccines and presence of government-sponsored programs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the human combination vaccines market covers the following areas:

  • Human combination vaccines market sizing
  • Human combination vaccines market forecast
  • Human combination vaccines market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human combination vaccines market vendors that include Abbott Laboratories, Arabio, Bharat Biotech Ltd., Biological E. Ltd., Cadila Healthcare Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Grifols SA, LG Corp., Meiji Holdings Co. Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Panacea Biotec Ltd., Pfizer Inc., PT Bio Farma, Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Walvax Biotechnology Co. Ltd. Also, the human combination vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR44620

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Channel
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global human combination vaccines market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global human combination vaccines market 2017 - 2021 ($ million)
  • 4.2 Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • 4.3 Channel Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Channel Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

  • 6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Inactivated vaccine - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
  • 6.4 Live attenuated vaccine - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Channel

  • 7.1 Market segments
  • Exhibit 43: Chart on Channel - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Channel - Market share 2022-2027 (%)
  • 7.2 Comparison by Channel
  • Exhibit 45: Chart on Comparison by Channel
  • Exhibit 46: Data Table on Comparison by Channel
  • 7.3 Hospitals - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
  • 7.4 Retailers - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Retailers - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Retailers - Year-over-year growth 2022-2027 (%)
  • 7.5 Online - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Online - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Online - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Online - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Online - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Channel
  • Exhibit 59: Market opportunity by Channel ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 63: Chart on Geographic comparison
  • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 UK - Market size and forecast 2022-2027
  • Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.9 Canada - Market size and forecast 2022-2027
  • Exhibit 89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.10 Japan - Market size and forecast 2022-2027
  • Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.11 Germany - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 101: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 104: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 105: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 106: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 107: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 108: Abbott Laboratories - Overview
  • Exhibit 109: Abbott Laboratories - Business segments
  • Exhibit 110: Abbott Laboratories - Key news
  • Exhibit 111: Abbott Laboratories - Key offerings
  • Exhibit 112: Abbott Laboratories - Segment focus
  • 12.4 Bharat Biotech Ltd.
  • Exhibit 113: Bharat Biotech Ltd. - Overview
  • Exhibit 114: Bharat Biotech Ltd. - Product / Service
  • Exhibit 115: Bharat Biotech Ltd. - Key news
  • Exhibit 116: Bharat Biotech Ltd. - Key offerings
  • 12.5 Biological E. Ltd.
  • Exhibit 117: Biological E. Ltd. - Overview
  • Exhibit 118: Biological E. Ltd. - Product / Service
  • Exhibit 119: Biological E. Ltd. - Key offerings
  • 12.6 Cadila Healthcare Ltd.
  • Exhibit 120: Cadila Healthcare Ltd. - Overview
  • Exhibit 121: Cadila Healthcare Ltd. - Business segments
  • Exhibit 122: Cadila Healthcare Ltd. - Key offerings
  • Exhibit 123: Cadila Healthcare Ltd. - Segment focus
  • 12.7 CSL Ltd.
  • Exhibit 124: CSL Ltd. - Overview
  • Exhibit 125: CSL Ltd. - Business segments
  • Exhibit 126: CSL Ltd. - Key news
  • Exhibit 127: CSL Ltd. - Key offerings
  • Exhibit 128: CSL Ltd. - Segment focus
  • 12.8 Daiichi Sankyo Co. Ltd.
  • Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibit 130: Daiichi Sankyo Co. Ltd. - Business segments
  • Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibit 133: Daiichi Sankyo Co. Ltd. - Segment focus
  • 12.9 GlaxoSmithKline Plc
  • Exhibit 134: GlaxoSmithKline Plc - Overview
  • Exhibit 135: GlaxoSmithKline Plc - Business segments
  • Exhibit 136: GlaxoSmithKline Plc - Key offerings
  • Exhibit 137: GlaxoSmithKline Plc - Segment focus
  • 12.10 Grifols SA
  • Exhibit 138: Grifols SA - Overview
  • Exhibit 139: Grifols SA - Business segments
  • Exhibit 140: Grifols SA - Key offerings
  • Exhibit 141: Grifols SA - Segment focus
  • 12.11 LG Corp.
  • Exhibit 142: LG Corp. - Overview
  • Exhibit 143: LG Corp. - Business segments
  • Exhibit 144: LG Corp. - Key offerings
  • Exhibit 145: LG Corp. - Segment focus
  • 12.12 Meiji Holdings Co. Ltd.
  • Exhibit 146: Meiji Holdings Co. Ltd. - Overview
  • Exhibit 147: Meiji Holdings Co. Ltd. - Business segments
  • Exhibit 148: Meiji Holdings Co. Ltd. - Key news
  • Exhibit 149: Meiji Holdings Co. Ltd. - Key offerings
  • Exhibit 150: Meiji Holdings Co. Ltd. - Segment focus
  • 12.13 Merck and Co. Inc.
  • Exhibit 151: Merck and Co. Inc. - Overview
  • Exhibit 152: Merck and Co. Inc. - Business segments
  • Exhibit 153: Merck and Co. Inc. - Key news
  • Exhibit 154: Merck and Co. Inc. - Key offerings
  • Exhibit 155: Merck and Co. Inc. - Segment focus
  • 12.14 Mitsubishi Chemical Holdings Corp.
  • Exhibit 156: Mitsubishi Chemical Holdings Corp. - Overview
  • Exhibit 157: Mitsubishi Chemical Holdings Corp. - Business segments
  • Exhibit 158: Mitsubishi Chemical Holdings Corp. - Key offerings
  • Exhibit 159: Mitsubishi Chemical Holdings Corp. - Segment focus
  • 12.15 Pfizer Inc.
  • Exhibit 160: Pfizer Inc. - Overview
  • Exhibit 161: Pfizer Inc. - Product / Service
  • Exhibit 162: Pfizer Inc. - Key news
  • Exhibit 163: Pfizer Inc. - Key offerings
  • 12.16 Sanofi SA
  • Exhibit 164: Sanofi SA - Overview
  • Exhibit 165: Sanofi SA - Business segments
  • Exhibit 166: Sanofi SA - Key news
  • Exhibit 167: Sanofi SA - Key offerings
  • Exhibit 168: Sanofi SA - Segment focus
  • 12.17 Serum Institute of India Pvt. Ltd.
  • Exhibit 169: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibit 170: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibit 171: Serum Institute of India Pvt. Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 172: Inclusions checklist
  • Exhibit 173: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 174: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 175: Research methodology
  • Exhibit 176: Validation techniques employed for market sizing
  • Exhibit 177: Information sources
  • 13.5 List of abbreviations
  • Exhibit 178: List of abbreviations
Product Code: IRTNTR44620

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Channel
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global human combination vaccines market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Channel Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Type - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Inactivated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Inactivated vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Live attenuated vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Live attenuated vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Type ($ million)
  • Exhibits43: Chart on Channel - Market share 2022-2027 (%)
  • Exhibits44: Data Table on Channel - Market share 2022-2027 (%)
  • Exhibits45: Chart on Comparison by Channel
  • Exhibits46: Data Table on Comparison by Channel
  • Exhibits47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Chart on Retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Data Table on Retailers - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Chart on Retailers - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on Retailers - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Chart on Online - Market size and forecast 2022-2027 ($ million)
  • Exhibits56: Data Table on Online - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Chart on Online - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on Online - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Market opportunity by Channel ($ million)
  • Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits63: Chart on Geographic comparison
  • Exhibits64: Data Table on Geographic comparison
  • Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Market opportunity By Geographical Landscape ($ million)
  • Exhibits102: Impact of drivers and challenges in 2022 and 2027
  • Exhibits103: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits104: Overview on factors of disruption
  • Exhibits105: Impact of key risks on business
  • Exhibits106: Vendors covered
  • Exhibits107: Matrix on vendor position and classification
  • Exhibits108: Abbott Laboratories - Overview
  • Exhibits109: Abbott Laboratories - Business segments
  • Exhibits110: Abbott Laboratories - Key news
  • Exhibits111: Abbott Laboratories - Key offerings
  • Exhibits112: Abbott Laboratories - Segment focus
  • Exhibits113: Bharat Biotech Ltd. - Overview
  • Exhibits114: Bharat Biotech Ltd. - Product / Service
  • Exhibits115: Bharat Biotech Ltd. - Key news
  • Exhibits116: Bharat Biotech Ltd. - Key offerings
  • Exhibits117: Biological E. Ltd. - Overview
  • Exhibits118: Biological E. Ltd. - Product / Service
  • Exhibits119: Biological E. Ltd. - Key offerings
  • Exhibits120: Cadila Healthcare Ltd. - Overview
  • Exhibits121: Cadila Healthcare Ltd. - Business segments
  • Exhibits122: Cadila Healthcare Ltd. - Key offerings
  • Exhibits123: Cadila Healthcare Ltd. - Segment focus
  • Exhibits124: CSL Ltd. - Overview
  • Exhibits125: CSL Ltd. - Business segments
  • Exhibits126: CSL Ltd. - Key news
  • Exhibits127: CSL Ltd. - Key offerings
  • Exhibits128: CSL Ltd. - Segment focus
  • Exhibits129: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits130: Daiichi Sankyo Co. Ltd. - Business segments
  • Exhibits131: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibits132: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits133: Daiichi Sankyo Co. Ltd. - Segment focus
  • Exhibits134: GlaxoSmithKline Plc - Overview
  • Exhibits135: GlaxoSmithKline Plc - Business segments
  • Exhibits136: GlaxoSmithKline Plc - Key offerings
  • Exhibits137: GlaxoSmithKline Plc - Segment focus
  • Exhibits138: Grifols SA - Overview
  • Exhibits139: Grifols SA - Business segments
  • Exhibits140: Grifols SA - Key offerings
  • Exhibits141: Grifols SA - Segment focus
  • Exhibits142: LG Corp. - Overview
  • Exhibits143: LG Corp. - Business segments
  • Exhibits144: LG Corp. - Key offerings
  • Exhibits145: LG Corp. - Segment focus
  • Exhibits146: Meiji Holdings Co. Ltd. - Overview
  • Exhibits147: Meiji Holdings Co. Ltd. - Business segments
  • Exhibits148: Meiji Holdings Co. Ltd. - Key news
  • Exhibits149: Meiji Holdings Co. Ltd. - Key offerings
  • Exhibits150: Meiji Holdings Co. Ltd. - Segment focus
  • Exhibits151: Merck and Co. Inc. - Overview
  • Exhibits152: Merck and Co. Inc. - Business segments
  • Exhibits153: Merck and Co. Inc. - Key news
  • Exhibits154: Merck and Co. Inc. - Key offerings
  • Exhibits155: Merck and Co. Inc. - Segment focus
  • Exhibits156: Mitsubishi Chemical Holdings Corp. - Overview
  • Exhibits157: Mitsubishi Chemical Holdings Corp. - Business segments
  • Exhibits158: Mitsubishi Chemical Holdings Corp. - Key offerings
  • Exhibits159: Mitsubishi Chemical Holdings Corp. - Segment focus
  • Exhibits160: Pfizer Inc. - Overview
  • Exhibits161: Pfizer Inc. - Product / Service
  • Exhibits162: Pfizer Inc. - Key news
  • Exhibits163: Pfizer Inc. - Key offerings
  • Exhibits164: Sanofi SA - Overview
  • Exhibits165: Sanofi SA - Business segments
  • Exhibits166: Sanofi SA - Key news
  • Exhibits167: Sanofi SA - Key offerings
  • Exhibits168: Sanofi SA - Segment focus
  • Exhibits169: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibits170: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibits171: Serum Institute of India Pvt. Ltd. - Key offerings
  • Exhibits172: Inclusions checklist
  • Exhibits173: Exclusions checklist
  • Exhibits174: Currency conversion rates for US$
  • Exhibits175: Research methodology
  • Exhibits176: Validation techniques employed for market sizing
  • Exhibits177: Information sources
  • Exhibits178: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!